If you liked this article you might like

Biotech Movers: Immunomedics, Aerie, Exelixis
Biotech Movers: Positive Phase Three Results For Roclatan Send Aerie Shares Soaring
Group Stink; Good, the Bad and the Ugly: Doug Kass' Views
Twitter, Netflix, MetLife: Doug Kass' Views